These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1856146)

  • 41. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.
    Giamarellou H; Yiallouros K; Petrikkos G; Moschovakis E; Vavouraki E; Voutsinas D; Sfikakis P
    J Antimicrob Chemother; 1991 May; 27 Suppl C():73-9. PubMed ID: 1906864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin.
    Verpooten GA; Giuliano RA; Verbist L; Eestermans G; De Broe ME
    Clin Pharmacol Ther; 1989 Jan; 45(1):22-7. PubMed ID: 2910634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of amikacin versus netilmicin in the treatment of severe infection in hospitalized patients.
    Noone M; Pomeroy L; Sage R; Noone P
    Am J Med; 1989 Jun; 86(6 Pt 2):809-13. PubMed ID: 2658582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.
    van Altena R; Dijkstra JA; van der Meer ME; Borjas Howard JF; Kosterink JG; van Soolingen D; van der Werf TS; Alffenaar JW
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.
    Powell SH; Thompson WL; Luthe MA; Stern RC; Grossniklaus DA; Bloxham DD; Groden DL; Jacobs MR; DiScenna AO; Cash HA; Klinger JD
    J Infect Dis; 1983 May; 147(5):918-32. PubMed ID: 6860416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonparallel nephrotoxicity dose-response curves of aminoglycosides.
    Hottendorf GH; Barnett D; Gordon LL; Christensen EF; Madissoo H
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1024-8. PubMed ID: 7271271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates.
    Vučićević K; Rakonjac Z; Miljković B; Janković B; Prostran M
    J Pharmacol Sci; 2014; 124(2):138-43. PubMed ID: 24441865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.
    Gerber AU; Kozak S; Segessenmann C; Flückiger U; Bangerter T; Greter U
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):233-7. PubMed ID: 2496992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.
    Sánchez-Alcaraz A; Vargas A; Quintana MB; Rocher A; Querol JM; Poveda JL; Hermenegildo M
    J Clin Pharm Ther; 1998 Oct; 23(5):367-73. PubMed ID: 9875685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ototoxic potential of netilmicin compared with amikacin. An animal study in guinea pigs.
    Wersäll J
    Scand J Infect Dis Suppl; 1980; Suppl 23():104-13. PubMed ID: 6970981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model.
    Schwank S; Blaser J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2258-61. PubMed ID: 8891125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C; Chaste A; Saison C; Combremont AG
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effects of aminoglycosides on renal cortical and urinary phospholipids in the rat.
    Josepovitz C; Levine R; Farruggella T; Kaloyanides GJ
    Proc Soc Exp Biol Med; 1986 May; 182(1):1-5. PubMed ID: 3960854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients.
    Krcméry V; Koza I; Mardiak J; Fuchsberger P; Spánik S; Trupl J; Horníková M; Kusenda Z; Sufliarsky J; Svec J
    Chemotherapy; 1992; 38(1):74-6. PubMed ID: 1618007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
    Bock BV; Edelstein PH; Meyer RD
    Antimicrob Agents Chemother; 1980 Feb; 17(2):217-25. PubMed ID: 6992711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative cochlear toxicities of streptomycin, gentamicin, amikacin and netilmicin in guinea-pigs.
    Kalkandelen S; Selimoğlu E; Erdoğan F; Uçüncü H; Altaş E
    J Int Med Res; 2002; 30(4):406-12. PubMed ID: 12235923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis.
    Fan ST; Lau WY; Teoh-Chan CH; Lau KF; Mauracher EH
    J Antimicrob Chemother; 1988 Jul; 22(1):69-74. PubMed ID: 3170392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.